,

CARTIVA™️ 60 MG

£325.00

Pre Filled Pen GoQuick

Product Description

CARTIVA™️ 60 MG

Move. Repair. Restore.

Experience advanced joint, cartilage, and connective-tissue research with CARTIVA™️ 60 MG, a targeted three-peptide complex combining Cartalax + TB-500 + BPC-157.

Designed around cartilage support, joint resilience, mobility, and tissue-repair pathways, CARTIVA™️ brings together Cartalax with two widely studied regenerative research peptides to create a specialized recovery complex.


The Science of Joint & Tissue Synergy

This advanced formulation combines three complementary peptides:

  • Cartalax (20 MG): A short peptide complex studied primarily in the context of cartilage biology, chondrocyte function, extracellular-matrix maintenance, and age-related cartilage changes.
  • TB-500 (20 MG): A thymosin beta-4–related research peptide investigated for mechanisms involving cell migration, tissue remodeling, flexibility, and recovery following physical stress.
  • BPC-157 (20 MG): An experimental peptide investigated mainly in preclinical research for its potential effects on tendons, ligaments, muscles, connective tissues, and tissue-repair pathways.

The result: Cartilage support + connective-tissue recovery + mobility + regenerative repair research.


Key Benefits

  • Supports cartilage-focused research
  • Supports joint and connective-tissue health
  • Promotes tissue-repair pathways
  • Supports tendon and ligament recovery research
  • Helps maintain mobility and flexibility
  • Supports extracellular-matrix processes
  • Promotes tissue remodeling following physical stress
  • Supports joint resilience
  • Supports recovery from intense physical activity
  • Provides a comprehensive musculoskeletal research platform

Crafted for Excellence

Designed for research focused on:

  • Cartilage and joint support
  • Tendon and ligament recovery
  • Connective-tissue resilience
  • Mobility and flexibility
  • Musculoskeletal recovery
  • Tissue remodeling
  • Recovery following intense physical activity
  • Long-term joint and cartilage research

Product Details

Cartalax + TB-500 + BPC-157

Advanced Joint & Connective Tissue Complex
Total: 60 MG

  • Cartalax (20 MG): Cartilage & Joint Support
  • TB-500 (20 MG): Mobility, Remodeling & Recovery Support
  • BPC-157 (20 MG): Tendon, Ligament & Connective-Tissue Recovery Research

Optimized Usage

For overall joint and recovery support:

  • Maintain adequate hydration
  • Follow a balanced, nutrient-rich diet
  • Prioritize sufficient protein intake
  • Maintain quality sleep and recovery
  • Incorporate appropriate mobility and flexibility work
  • Avoid excessive repetitive joint stress
  • Follow a structured training and recovery program

Refined Protocol

  • Research Duration: Commonly evaluated over several weeks depending on the research objective.
  • Administration: Route, concentration, and frequency should follow the specific research protocol and qualified professional guidance.

Advanced Stacking & Synergy

Depending on the research objective, CARTIVA™️ may be studied alongside:

  • Collagen Peptides: Supports structural nutrition for cartilage and connective tissue.
  • Vitamin C: Supports normal collagen formation.
  • Magnesium Glycinate: Supports normal muscle function and recovery.
  • CJC-1295 + Ipamorelin: Studied in recovery and growth-hormone pathway research.

Possible Side Effects

Individual responses may vary. Potential reactions associated with compounds in this category may include:

  • Temporary headache
  • Mild fatigue
  • Temporary nausea
  • Local irritation or sensitivity
  • Temporary digestive discomfort

Scientific Perspective

Cartalax belongs to a category of short peptide complexes investigated for potential effects on cartilage-cell activity and extracellular-matrix regulation. Human evidence remains limited, so these findings should be considered exploratory.

TB-500–related compounds are studied for mechanisms associated with cellular migration and tissue remodeling.

BPC-157 remains an experimental peptide, with much of its reported regenerative evidence coming from laboratory and animal studies rather than established human clinical use.

Together, Cartalax + TB-500 + BPC-157 create a specialized research platform centered on cartilage, joints, connective tissue, mobility, and regenerative recovery.


Why Choose Stayfit Pharma

When quality matters, precision defines the difference.

  • 99%+ purity peptides
  • Manufactured under strict quality standards
  • Advanced formulations for performance and research
  • Premium-grade ingredients and quality control

CARTIVA™️ 60 MG
Cartalax 20 MG + TB-500 20 MG + BPC-157 20 MG
Advanced Joint & Connective Tissue Complex
Cartilage • Mobility • Repair • Recovery

Shopping Cart
The product has been successfully added to the cart, View Cart
Scroll to Top